TīmeklisNational Center for Biotechnology Information Tīmeklis2013. gada 10. janv. · The FAB/LMB 96 study was an open-label, randomized cooperative international study involving 161 pediatric cancer centers in 3 national groups: the Societé Française d'Oncologie Pediatrique (SFOP: France, Belgium, and The Netherlands), Children's Oncology Group (COG; United States, Canada, and …
Overall survival of children and adolescents with mature B cell non ...
Tīmeklis2012. gada 3. sept. · In the prior FAB/LMB 96 study, which utilized the same FAB/LMB 96 chemotherapy only, the 5-year EFS in patients with stage III/IV B-NHL was 84% … TīmeklisCairo M, Auperin A, Perkins SL, et al.: Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group. Br J Haematol 182 (6): 859-869, 2024. [PUBMED Abstract] Griffin TC, Weitzman S, … ehs cornell eyewash
Results of the randomized international FAB/LMB96 trial …
Tīmeklis2024. gada 9. jūl. · We determined the risk factors associated with poor survival in children and adolescents with de novo mature B cell non-Hodgkin lymphoma (B-NHL) who had refractory or relapsed disease during or after the French-American-British mature lymphoma B (FAB/LMB) 96 multi-agent chemotherapy. Among the 1 111 … TīmeklisDownload scientific diagram LMB 96 protocol schedule [8]. Patients were stratified into 3 risk groups: A, B, and C, depending on stage, resection status, percentage of … Tīmeklis2024. gada 23. aug. · The Berlin-Frankfurt-Munster Group reported pooled outcomes of children and adolescents with PMBCL treated in successive prospective trials from 1986 to 1999. Among 30 patients, the 5-year EFS was 70%. 30 The international FAB/LMB 96 mature B-cell NHL (B-NHL ehs confined space